Therapeutic windows and opportunity cost cast upon prostate cancer's fatal shore. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Jul 2013
- 1717-1720 p. digital
Publication Type: Editorial; Comment
1569-8041
10.1093/annonc/mdt234 doi
Androstenes Androstenols--therapeutic use Antineoplastic Agents--pharmacology Antineoplastic Combined Chemotherapy Protocols--therapeutic use Benzamides Bone Neoplasms--drug therapy Docetaxel Humans Male Nitriles Phenylthiohydantoin--analogs & derivatives Prostatic Neoplasms--drug therapy Taxoids--pharmacology